What does LIDEFARMA do?

LIDEFARMA is a pharmacy in Lierde. Private Limited, started on 7 August 2008, 1 establishment.

What is the address of LIDEFARMA?

The registered office of LIDEFARMA is located at Kerkstraat 24A box 2, 9570 Lierde.

Is LIDEFARMA still active?

Yes. According to the CBE (30 October 2026) LIDEFARMA is active, legal situation “Normale toestand”, started on 7 August 2008.

Is LIDEFARMA registered on Peppol?

Yes, LIDEFARMA is registered on the Peppol network with ID 0208:0899688064.

What is the enterprise number of LIDEFARMA?

The enterprise number of LIDEFARMA is BE0899688064.

When was LIDEFARMA founded?

LIDEFARMA was founded on 7 August 2008.

Who are the directors of LIDEFARMA?

According to the 2025 annual accounts, the directors of LIDEFARMA are: Greet Willemsen, Luc Breckx.

Is LIDEFARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 August 2008; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did LIDEFARMA make in 2025?

LIDEFARMA posted a profit after taxes of € 62,177 in financial year 2025.

What is the revenue of LIDEFARMA?

As a small company, LIDEFARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 146,809.

Does LIDEFARMA have a website?

Yes, LIDEFARMA has a website at apotheekdeftinge.be.

LIDEFARMA (Private Limited) - Lierde - BE0899688064

Dossier LIDEFARMA, printed on 30 October 2026 from databakkes.be/en/0899688064/lidefarma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LIDEFARMA from Lierde, company number BE0899688064, closed financial year 2025 with a result of € 62,177 after tax. For that financial year LIDEFARMA recorded a gross margin of € 146,809 and equity of € 315,147. Compared with financial year 2024, the result moved from € 25,890 to € 62,177. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Growing

€ 315,147

▲ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 62,177

▲ 140% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 102,559

▲ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 32,527 paid out

52 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 21,697

▼ 21% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 115,779

▲ 66% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 79,838

▲ 68% vs 2024

€ 65,659 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 49,181

▲ 17% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,989

▲ 56% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 108,573 Gross margin 2022: € 108,573 First fiscal year in the series	€ 106,797 Gross margin 2023: € 106,797 ▼ 2% vs 2022 (€ 108,573) Unfavourable step	€ 88,416 Gross margin 2024: € 88,416 ▼ 17% vs 2023 (€ 106,797) Unfavourable step	€ 146,809 Gross margin 2025: € 146,809 ▲ 66% vs 2024 (€ 88,416) Favourable step	▲ 66%
Profit after taxes	€ 56,133 Profit after taxes 2022: € 56,133 First fiscal year in the series	€ 46,102 Profit after taxes 2023: € 46,102 ▼ 18% vs 2022 (€ 56,133) Unfavourable step	€ 25,890 Profit after taxes 2024: € 25,890 ▼ 44% vs 2023 (€ 46,102) Unfavourable step	€ 62,177 Profit after taxes 2025: € 62,177 ▲ 140% vs 2024 (€ 25,890) Favourable step	▲ 140%
Equity	€ 272,804 Equity 2022: € 272,804 First fiscal year in the series	€ 259,607 Equity 2023: € 259,607 ▼ 5% vs 2022 (€ 272,804) Unfavourable step	€ 285,497 Equity 2024: € 285,497 ▲ 10% vs 2023 (€ 259,607) Favourable step	€ 315,147 Equity 2025: € 315,147 ▲ 10% vs 2024 (€ 285,497) Favourable step	▲ 10%
Total debts	€ 187,464 Total debts 2022: € 187,464 First fiscal year in the series	€ 113,539 Total debts 2023: € 113,539 ▼ 39% vs 2022 (€ 187,464) Favourable step	€ 101,421 Total debts 2024: € 101,421 ▼ 11% vs 2023 (€ 113,539) Favourable step	€ 179,880 Total debts 2025: € 179,880 ▲ 77% vs 2024 (€ 101,421) Unfavourable step	▲ 77%
Cash	€ 108,549 Cash 2022: € 108,549 First fiscal year in the series	€ 103,689 Cash 2023: € 103,689 ▼ 4% vs 2022 (€ 108,549) Unfavourable step	€ 85,077 Cash 2024: € 85,077 ▼ 18% vs 2023 (€ 103,689) Unfavourable step	€ 102,559 Cash 2025: € 102,559 ▲ 21% vs 2024 (€ 85,077) Favourable step	▲ 21%
Land & buildings	€ 17,245 Land & buildings 2022: € 17,245 First fiscal year in the series	€ 8,978 Land & buildings 2023: € 8,978 ▼ 48% vs 2022 (€ 17,245) Unchanged	€ 711 Land & buildings 2024: € 711 ▼ 92% vs 2023 (€ 8,978) Unchanged	€ 0 Land & buildings 2025: € 0 ▼ 100% vs 2024 (€ 711) Unchanged	▼ 100%
Retained profit	€ 254,204 Retained profit 2022: € 254,204 First fiscal year in the series	€ 241,007 Retained profit 2023: € 241,007 ▼ 5% vs 2022 (€ 254,204) Unfavourable step	€ 266,897 Retained profit 2024: € 266,897 ▲ 11% vs 2023 (€ 241,007) Favourable step	€ 296,547 Retained profit 2025: € 296,547 ▲ 11% vs 2024 (€ 266,897) Favourable step	▲ 11%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 59,299 Dividend 2023: € 59,299 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 59,299) Unchanged	€ 32,527 Dividend 2025: € 32,527 Unchanged (€ 0) Unchanged
Bank debt	€ 90,449 Bank debt 2022: € 90,449 First fiscal year in the series	€ 69,036 Bank debt 2023: € 69,036 ▼ 24% vs 2022 (€ 90,449) Favourable step	€ 47,382 Bank debt 2024: € 47,382 ▼ 31% vs 2023 (€ 69,036) Favourable step	€ 79,838 Bank debt 2025: € 79,838 ▲ 68% vs 2024 (€ 47,382) Unfavourable step	▲ 68%
Balance sheet total	€ 460,268 Balance sheet total 2022: € 460,268 First fiscal year in the series	€ 373,146 Balance sheet total 2023: € 373,146 ▼ 19% vs 2022 (€ 460,268) Unchanged	€ 386,918 Balance sheet total 2024: € 386,918 ▲ 4% vs 2023 (€ 373,146) Unchanged	€ 495,027 Balance sheet total 2025: € 495,027 ▲ 28% vs 2024 (€ 386,918) Unchanged	▲ 28%

Key figures of LIDEFARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LIDEFARMA?

What happened at LIDEFARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: profit of € 62,177 (▲ 140% vs 2024). filed late Source: NBB ↗
Aug 7, 2008 New establishment in Lierde. KBO
Aug 7, 2008 Start of the company according to the CBE. KBO

In short

From € 56,133 profit in 2022 to € 62,177 profit in 2025.

Paid € 65,566 in corporate taxes since 2022.

Best year ever: 2025, with € 62,177 profit.

Paid out € 91,827 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Greet Willemsen Luc Breckx

LIDEFARMA

Behind LIDEFARMA are Greet Willemsen and Luc Breckx.

Directors

According to the 2025 annual accounts

Greet Willemsen

Director

Luc Breckx

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkstraat 24A box 2

9570 Lierde

2.173.076.449

Kerkstraat 32 box A

9570 Lierde

Active since 7 August 2008

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Vereniging van medeeigenaars Residentie DE DRIE BERKEN te Lierde (Deftinge), Kerkstraat 24/A

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekdeftinge.be

Technologies

BootstrapChart.jsCloudflare CDNDiviElementorFacebook PixelFont AwesomeGoogle FontsPHPSwiperWP RocketWPMLWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Website info

HTTPS Ja

Languages NL

Features

Webshop Blog Ads Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0899.688.064

VAT number

BE 0899.688.064

Registered office

Kerkstraat 24A bus 2, 9570 Lierde

Names & denominations

LIDEFARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

7 August 2008

Peppol

Active · Active since 24 Nov 2023

Contact

apotheekdeftinge.be

Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van holdings

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige zakelijke dienstverlening, neg

Holdings

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

LIDEFARMA

Financials

What happened to LIDEFARMA?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions